FDA inspection

Lonza AG: FDA inspection ending Nov 4, 2022

FDA inspection 1191869 · No Action Indicated (NAI) · Basel Town

Key facts

Inspection ID 1191869
Firm Lonza AG
FEI number 3014753648
Address Hochbergerstrasse 60a
City Basel Town
Country Switzerland
Fiscal year 2023
Inspection end date Nov 4, 2022
Classification No Action Indicated (NAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • No Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections